{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:39:27Z","timestamp":1791319167584,"version":"4.3.1"},"reference-count":32,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,12,25]]},"DOI":"10.1253\/circj.cj-25-0285","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T22:07:39Z","timestamp":1754777259000},"page":"99-108","source":"Crossref","is-referenced-by-count":4,"title":["Catheter Ablation of Ventricular Tachycardia in Histologically Confirmed, Clinically Diagnosed, and Suspected Cardiac Sarcoidosis"],"prefix":"10.1253","volume":"90","author":[{"given":"Juan F.","family":"Rodriguez-Riascos","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema Srikanth","family":"Vemulapalli","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poojan","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmapriya","family":"Muthu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Sorajja","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton E.","family":"Jokerst","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Rojas","sequence":"additional","affiliation":[{"name":"Cardiothoracic Radiology Department, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"El Masry","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komandoor","family":"Srivathsan","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. <i>Am J Respir Crit Care Med<\/i> 2001; 164: 1885\u20131889.","DOI":"10.1164\/ajrccm.164.10.2104046"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, et al. Detection of myocardial damage in patients with sarcoidosis. <i>Circulation<\/i> 2009; 120: 1969\u20131977.","DOI":"10.1161\/CIRCULATIONAHA.109.851352"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, et al. Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study. <i>Circulation<\/i> 2015; 131: 624\u2013632.","DOI":"10.1161\/CIRCULATIONAHA.114.011522"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. P\u00f6yh\u00f6nen P, Lehtonen J, Velikanova D, Simonen P, Uusitalo V, M\u00e4lk\u00f6nen H, et al. 30-year trends in the incidence, characteristics, and outcome of cardiac sarcoidosis in a nationwide cohort. <i>JACC Adv<\/i> 2024; 3: 101102.","DOI":"10.1016\/j.jacadv.2024.101102"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Desai R, Kakumani K, Fong HK, Shah B, Zahid D, Zalavadia D, et al. The burden of cardiac arrhythmias in sarcoidosis: A population-based inpatient analysis. <i>Ann Transl Med<\/i> 2018; 6: 330\u2013330.","DOI":"10.21037\/atm.2018.07.33"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. <i>Am Heart J<\/i> 1999; 138: 299\u2013302.","DOI":"10.1016\/S0002-8703(99)70115-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis: Digest version. <i>Circ J<\/i> 2019; 83: 2329\u20132388.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"8","unstructured":"8. Judson M, Baughman R, Teirstein A, Terrin M, Yeayer H Jr. Defining organ involvement in sarcoidosis: The ACCESS proposed instrument. ACCESS Research group. A Case Control Etiologic Study of Sarcoidosis. <i>Sarcoidosis Vasc Diffuse Lung Dis<\/i> 1999; 16: 75\u201386."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. <i>Heart Rhythm<\/i> 2014; 11: 1304\u20131323.","DOI":"10.1016\/j.hrthm.2014.03.043"},{"key":"10","unstructured":"10. The Japan Society of Sarcoidosis and Other Granulomatous Disorders, the Diffuse Pulmonary Study Group of the Health and Labor Sciences Research Grant-supported Rare\/Intractable Disease Project, et al. Committee for revision of the diagnostic standard for sarcoidosis. Diagnostic standard and guideline for sarcoidosis \u2013 2006. <i>Jpn J Sarcoidosis Granulomatous Disord<\/i> 2007; 27: 89\u2013102 [in Japanese]."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vemulapalli HS, Rodriguez-Riascos JF, Muthu P, Prajapati P, Raman A, Iyengar S, et al. Epicardial access for ventricular tachycardia and premature ventricular complexes ablation: An institutional experience. <i>Heart Rhythm O2<\/i> 2025; 6: 204\u2013213.","DOI":"10.1016\/j.hroo.2024.11.020"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Siontis KC, Santangeli P, Muser D, Marchlinski FE, Zeppenfeld K, Hoogendoorn JC, et al. Outcomes associated with catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis. <i>JAMA Cardiol<\/i> 2022; 7: 175.","DOI":"10.1001\/jamacardio.2021.4738"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kaur D, Roukoz H, Shah M, Yalagudri S, Pandurangi U, Chennapragada S, et al. Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis. <i>J Cardiovasc Electrophysiol<\/i> 2020; 31: 612\u2013620.","DOI":"10.1111\/jce.14341"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Muser D, Santangeli P, Pathak RK, Castro SA, Liang JJ, Magnani S, et al. Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis. <i>Circ Arrhythm Electrophysiol<\/i> 2016; 9: e004333.","DOI":"10.1161\/CIRCEP.116.004333"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kumar S, Barbhaiya C, Nagashima K, Choi EK, Epstein LM, John RM, et al. Ventricular tachycardia in cardiac sarcoidosis: Characterization of ventricular substrate and outcomes of catheter ablation. <i>Circ Arrhythm Electrophysiol<\/i> 2015; 8: 87\u201393.","DOI":"10.1161\/CIRCEP.114.002145"},{"key":"16","unstructured":"16. Bandyopadhyay D, Sahoo D, Zein J, Brunken R, Tchou P, Culver D. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD: A propesity matched analysis. <i>Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2015; 32: 70\u201379."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tokuda M, Tedrow UB, Kojodjojo P, Inada K, Koplan BA, Michaud GF, et al. Catheter ablation of ventricular tachycardia in nonischemic heart disease. <i>Circ Arrhythm Electrophysiol<\/i> 2012; 5: 992\u20131000.","DOI":"10.1161\/CIRCEP.112.971341"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Jefic D, Joel B, Good E, Morady F, Rosman H, Knight B, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: Report from a multicenter registry. <i>Heart Rhythm<\/i> 2009; 6: 189\u2013195.","DOI":"10.1016\/j.hrthm.2008.10.039"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG. Refractory ventricular tachycardia secondary to cardiac sarcoid: Electrophysiologic characteristics, mapping, and ablation. <i>Heart Rhythm<\/i> 2006; 3: 924\u2013929.","DOI":"10.1016\/j.hrthm.2006.03.031"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kusano K, Ishibashi K, Noda T, Nakajima K, Nakasuka K, Terasaki S, et al. Prognosis and outcomes of clinically diagnosed cardiac sarcoidosis without positive endomyocardial biopsy findings. <i>JACC Asia<\/i> 2021; 1: 385\u2013395.","DOI":"10.1016\/j.jacasi.2021.09.005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Isobe M, Tezuka D. Isolated cardiac sarcoidosis: Clinical characteristics, diagnosis and treatment. <i>Int J Cardiol<\/i> 2015; 182: 132\u2013140.","DOI":"10.1016\/j.ijcard.2014.12.056"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. De Bortoli A, Birnie DH. Diagnosis and treatment of cardiac sarcoidosis. <i>Circ J<\/i> 2023; 87: 471\u2013480.","DOI":"10.1253\/circj.CJ-22-0671"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mactaggart S, Ahmed R. Comparison of prognosis in isolated versus systemic manifestations of cardiac sarcoidosis. <i>Curr Probl Cardiol<\/i> 2024; 49: 102671.","DOI":"10.1016\/j.cpcardiol.2024.102671"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yoshida S, Nakata T, Naya M, Momose M, Taniguchi Y, Fukushima Y, et al. Prognostic implications of sarcoidosis granulomas: Insights from the multicenter registry, the Japanese Cardiac Sarcoidosis Prognostic Study. <i>Circ Rep<\/i> 2023; 5: 252\u2013259.","DOI":"10.1253\/circrep.CR-23-0031"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Devesa A, Robson PM, Cangut B, Vazirani R, Vergani V, LaRocca G, et al. Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis. <i>Heart Rhythm<\/i> 2025; 22: 1606\u20131614.","DOI":"10.1016\/j.hrthm.2024.09.011"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. <i>Am J Cardiol<\/i> 2009; 104: 571\u2013577.","DOI":"10.1016\/j.amjcard.2009.03.068"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ramirez R, Trivieri M, Fayad ZA, Ahmadi A, Narula J, Argulian E. Advanced imaging in cardiac sarcoidosis. <i>J Nucl Med<\/i> 2019; 60: 892\u2013898.","DOI":"10.2967\/jnumed.119.228130"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sykora D, Bratcher M, Churchill R, Kim BM, Elwazir M, Young K, et al. Medical therapy and clinical outcomes in cardiac sarcoidosis patients with systolic heart failure. <i>Circ J<\/i> 2024; 89: 41\u201352.","DOI":"10.1253\/circj.CJ-24-0205"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Muthu P, Prajapati P, Vemulapalli H, Rodriguez-Riascos JF, Raman A, Srivathsan K. Ablation of premature ventricular complexes originating from papillary muscle using pulsed field energy: The first in USA experience. <i>Heart Rhythm<\/i> 2024, doi:10.1016\/j.hrthm.2024.10.067.","DOI":"10.1016\/j.hrthm.2024.10.067"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Prajapati P, Muthu P, Vemulapalli HS, Rodriguez-Riascos JF, Raman A, Srivathsan K. Rescuing failed radiofrequency ablation: Pulsed field ablation in ventricular tachycardia. <i>HeartRhythm Case Rep<\/i> 2025; 11: 223\u2013228.","DOI":"10.1016\/j.hrcr.2024.11.018"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Takaya Y, Nakagawa K, Miyoshi T, Nishii N, Morita H, Nakamura K, et al. Impact of high-sensitivity cardiac troponin T on clinical outcomes in patients with cardiac sarcoidosis. <i>Circ J<\/i> 2025; 89: 442\u2013449.","DOI":"10.1253\/circj.CJ-24-0801"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kataoka S, Yagishita D, Yazaki K, Kanai M, Hasegawa S, Shoda M, et al. Prolonged T-peak to T-end interval predicts implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. <i>Circ J<\/i> 2023; 87: 1058\u20131067.","DOI":"10.1253\/circj.CJ-23-0058"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/1\/90_CJ-25-0285\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:18:24Z","timestamp":1766805504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/1\/90_CJ-25-0285\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0285","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"article-number":"CJ-25-0285"}}